News Briefs

HHS and the Dept. of Defense reached a deal with CVS Health Corp. and Walgreen Co. to provide and administer COVID-19 vaccines to residents of long-term care facilities (LTCF) nationwide, with no out-of-pocket costs for patients, once they become available. The goal of the partnership is to “minimize the burden” on LTCF sites and jurisdictional health departments regarding vaccine handling, administration and fulfilling reporting requirements, HHS said in an Oct. 16 press release. In its own press release, CVS said it “has the experience and expertise to play a vital role in the COVID-19 vaccination effort,” noting that it’s now administered more than 5 million COVID-19 tests since the start of the pandemic. Read more at https://bit.ly/3jhCsTS.

Highmark Inc. says it has been able to improve safety and reduce costs for patients with diabetes through “an innovative process that identifies opportunities to discontinue clinically ineffective prescriptions and flags dangerous medication combinations.” The Pittsburgh-based insurer touted its model, which “combines medical and pharmacy data and partners with primary care physicians to improve diabetes medication management,” at the Academy of Managed Care Pharmacy Nexus 2020 Virtual Conference on Oct. 19. The program is available to practices that participate in Highmark’s True Performance value-based reimbursement initiative. Read more about Highmark’s diabetes program at https://bit.ly/2FRiim8.

© 2023 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

bills-and-pills
January 26

Medicare Enrollees May Still Face Affordability Issues After Part D Benefit Redesign

READ MORE
pills-in-hand
January 26

ICER Report Aims to Nudge Payers Toward Fairer Drug Coverage Policies

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
January 26

News Briefs: Lilly Alzheimer’s Drug Fails to Win Accelerated Approval

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today